An audit of the use of high dose neuroleptics in treating schizophrenia

被引:0
|
作者
Tyson, PJ [1 ]
Mortimer, A [1 ]
Wheeler, JA [1 ]
机构
[1] Univ Hull, Dept Psychiat, Hull HU10 6ED, N Humberside, England
关键词
D O I
10.1016/S0920-9964(97)88700-2
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:156 / 156
页数:1
相关论文
共 50 条
  • [41] Use of very-high-dose olanzapine in treatment-resistant schizophrenia
    Batail, J. -M.
    Langree, B.
    Robert, G.
    Bleher, S.
    Verdier, M. -C.
    Bellissant, E.
    Millet, B.
    Drapier, D.
    SCHIZOPHRENIA RESEARCH, 2014, 159 (2-3) : 411 - 414
  • [42] DEPOT NEUROLEPTICS IN THE MAINTENANCE TREATMENT OF SCHIZOPHRENIA
    PROKOPOVA, Z
    BOLELOUCKY, Z
    VINAROVA, E
    ACTIVITAS NERVOSA SUPERIOR, 1985, 27 (01): : 58 - 58
  • [43] Prevalence of High-dose Antipsychotic Prescribing in Schizophrenia: A Clinical Audit in a Regional Queensland Mental Health Service
    Luthra, Shalini
    Duggan, Lorna
    Agrawal, Aanchal
    Kaur, Gurpreeti
    Luthra, Neeru
    INTERNATIONAL JOURNAL OF APPLIED AND BASIC MEDICAL RESEARCH, 2023, 13 (02) : 70 - 76
  • [44] BIOCHEMISTRY OF SCHIZOPHRENIA AND MODE OF ACTION OF NEUROLEPTICS
    LOO, H
    CUCHE, H
    SECHTER, D
    SEMAINE DES HOPITAUX, 1982, 58 (44): : 2565 - 2572
  • [45] DOPAMINE-RECEPTORS, NEUROLEPTICS, AND SCHIZOPHRENIA
    SNYDER, SH
    AMERICAN JOURNAL OF PSYCHIATRY, 1981, 138 (04): : 460 - 464
  • [46] Atypical neuroleptics and selective attention in schizophrenia
    Stip, E
    Lussier, I
    Lalonde, P
    Luyet, A
    Fabian, J
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 1999, 25 (03): : 260 - 264
  • [47] Antipsychotic drug use patterns and the cost of treating schizophrenia
    McCombs, JS
    Nichol, MB
    Johnstone, BM
    Stimmel, GL
    Shi, JH
    Smith, R
    PSYCHIATRIC SERVICES, 2000, 51 (04) : 525 - 527
  • [48] SURVEY OF THE ADJUVANT USE OF BENZODIAZEPINES FOR TREATING OUTPATIENTS WITH SCHIZOPHRENIA
    PECKNOLD, JC
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 1993, 18 (02): : 82 - 84
  • [49] INFLUENCE OF NEUROLEPTICS ON SYMPTOM STRUCTURE IN SCHIZOPHRENIA
    WHITE, L
    PARRELLA, M
    HARVEY, PD
    KEEFE, R
    DAVIDSON, M
    SCHIZOPHRENIA RESEARCH, 1995, 15 (1-2) : 23 - 24
  • [50] ATYPICAL NEUROLEPTICS AND NEUROPSYCHOLOGICAL FUNCTION IN SCHIZOPHRENIA
    TAYLOR, SF
    GOLDMAN, R
    SMET, IC
    TANDON, R
    BIOLOGICAL PSYCHIATRY, 1995, 37 (09) : 675 - 675